Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression and clinical significance of programmed death ligand 1 in nasopharyngeal carcinoma

21 May 2018

Abstract excerpt

Nasopharyngeal carcinoma (NPC) has the highest incidence of all types of head and neck cancer in China. The present study aimed to investigate the association between the expression of programmed death ligand 1 (PD‑L1) in NPC tissues and clinicopathological features, as well the outcomes for NPC patients. In addition, the association between tissue expression of PD‑L1 and immune components in peripheral blood was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Cancer-related Molecular Pathways
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29977542
DOI: 10.3892/mco.2018.1633

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression and clinical significance of programmed death ligand 1 in nasopharyngeal carcinomaPMID 29977542Read ↗

Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinoma.Semantic proximity Read ↗

Focusing on the Abnormal Events of NPC1, NPC2, and NPC1L1 in Pan-Cancer and Further Constructing LUAD and KICH Prediction Models.Semantic proximity Read ↗

Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome expression could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti–programmed cell death 1 monotherapySemantic proximity Read ↗

Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapySemantic proximity Read ↗

Epstein-Barr Virus BRLF1 Induces PD-L1 Expression in Nasopharyngeal Carcinoma CellsSemantic proximity Read ↗

Nasopharyngeal carcinoma: molecular biomarker discovery and progress.Semantic proximity Read ↗

PD-1 and PD-L1 Expression Levels as a Potential Biomarker of Chronic Rhinosinusitis and Head and Neck CancersSemantic proximity Read ↗

Programmed cell death in nasopharyngeal carcinoma: Mechanisms and therapeutic targetsSemantic proximity Read ↗

Molecular diagnosis of nasopharyngeal carcinoma: Past and future.Semantic proximity Read ↗

Updates on Epstein–Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBVSemantic proximity Read ↗

Emerging roles of lncRNA in Nasopharyngeal Carcinoma and therapeutic opportunitiesSemantic proximity Read ↗

The current status and future of PD-L1 in liver cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.